Cambridge Angels group

Cambridge Angels group

Signal active

Investment Firm

Overview

The Cambridge Angels are a group of high-net worth investors who have proven experience as successful entrepreneurs in internet, software, technology and bio-technology. Members invest in and mentor high quality start-up and early-stage companies in these sectors in the Cambridge (UK) area and throughout the UK.

Typical funding requirements that the Cambridge Angels meet are in the range of £50,000 to £500,000 - although it is worth noting that several of their portfolio companies have received more than £1m in funding from their Members over several funding rounds.

Their Members have been responsible for a large number of the “Cambridge Phenomenon” success stories over recent years. Therefore, in addition to providing funding for early-stage companies, the Cambridge Angels also offer start-ups the considerable benefit of a wide range of expertise, contacts and directly relevant experience in establishing and growing entrepreneurial businesses successfully.

Highlights

Founded

1999

Industry

Financial Services

Employees

51-100

Investment

126

Lead Investment

21

Exits

14

Stages

Seed, Late Stage Venture, Early Stage Venture

Investor Type

Angel Group

Location

Europe

Contact Information

Social

Profile Resume

Cambridge Angels group, established in 1999 and headquartered in Europe., specializes in Seed, Late Stage Venture, Early Stage Venture investments across Software, Social Network, Mobile, Infrastructure, Telecommunications, Hardware, Financial Services, Venture Capital, Finance, Information Technology. The organization boasts a portfolio of 125 investments, with an average round size of $3.4M and 14 successful exits. Their recent investments include Trutap, Nujira, Amadeus Capital Partners, 3i Group, BankInvest. The highest investment round they participated in was $21.4B. Among their most notable exits are Trutap and Nujira. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Doug Richard

Doug Richard

Founder

imagePlace Robert Sansom

Robert Sansom

Founder

imagePlace David Cleevely

David Cleevely

CoFounder

imagePlace Pete Hutton

Pete Hutton

Angel Investor

imagePlace Richard Parmee

Richard Parmee

Angel Investor

Investment portfolio

Cambridge Angels group has made 126 investments. Their most recent investment was on Jul 18, 2024, when xWatts raised $1.8M.

Cambridge Angels group has made 2 diversity investments. Their most recent diversity investment was on Nov 30, 2016, when Exonate raised $1.9M.

investments

126

Diversity investments

2

Lead investments

21

Number of exits

14

Investments

126

Annouced DateOrganization NameIndustryMoney Raised
Feb 12, 2024
BugBiome BugBiome
Biotechnology391.4K
Apr 15, 2024
Qureight Qureight
Machine Learning8.5M
Apr 18, 2024
Monument Therapeutics Monument Therapeutics
Biotechnology1.2M
Jul 18, 2024
xWatts xWatts
Software1.8M

Exits

14

Funding Timeline

Funding rounds

126

Investors

0

Funds

0

Funding Rounds

126

Cambridge Angels group has raised 126 rounds. Their latest funding was raised on Jul 18, 2024 from a Pre Seed Round - xWatts round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Feb 12, 2024
Pre Seed Round - BugBiome Pre Seed Round - BugBiome
-391.4K-
Apr 15, 2024
Series A - Qureight Series A - Qureight
-8.5M-
Apr 18, 2024
Venture Round - Monument Therapeutics Venture Round - Monument Therapeutics
-1.2M-
Jul 18, 2024
Pre Seed Round - xWatts Pre Seed Round - xWatts
-1.8M-

Investors

0

There is no funding round available on this profile

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.